Immunotherapy startup CytomX raises $70M; IPO on horizon
The Bay Area immunotherapy player targets PD-L1 and "Probody" drug conjugates. It'll use the $70 million to advance several candidates into the clinic.
The Bay Area immunotherapy player targets PD-L1 and "Probody" drug conjugates. It'll use the $70 million to advance several candidates into the clinic.
Outset Medical has developed an all-in-one dialysis machine that could reduce providers' overhead - changing the service model and cutting staff.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
EndoGastric Solutions has raised more than $160 million for its device that one-ups laparoscopy - it helps surgeons conduct stomach surgery through the mouth, so no incisions need to be made.
The Bay Area startup has a minimally invasive treatment for lower back pain that's caused by sacroilial joint dysfunction. It raised $21 million to commercialize the therapy in the U.S. and Europe.
Outset Medical just raised $60 million - and possibly more - to build out its at-home dialysis machine for patients with kidney failure.
Shockwave Medical just got $40M for its technology that breaks up plaques in vascular disease - much like the lithotripsy used to treat kidney stones.
Bay Area medtech startup Moximed just raised an impressive $33 million round for its knee implant that preserve joint integrity – particularly for osteoarthritic patients in line for arthroplasty. The funding will help Moximed gain FDA approval for this KineSpring System, and expand commercial sales in Europe. The round includes new investors Vertex Venture Holdings, as well […]
Bay Area cancer vaccine maker Bullet Biotechnology is developing a therapy for B cell lymphomas, hacking a patient’s own immune system to treat these cancers. It takes the typical vaccine approach – targeting a marker exclusive to B cells that elicits a cellular immune response – from both T and B cells. Bullet uses directed conjugation to attach a […]
In vitro fertilization is a tough process. Even if a set of embryos are able to form, it’s a real crapshoot to see which – if any – will actually be viable. Bay Area biotech Auxogyn has developed a test to track whether an embryo is developing successfully – and has raised a healthy swath of cash to commercialize its fresh-on-the-market […]
Bay Area smart stethoscope company Eko Devices just raised $2 million, bringing the UC Berkeley spinout’s total funding up to $2.8 million. Its device, called Core, attaches to an analog stethoscope, and via Bluetooth connectivity sends the data back to an app that allows clinicians to visualize, record, play back, share and analyze sounds. Funding comes […]
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Invuity, a Bay Area medtech that builds surgical tools to help illuminate a patient’s innards during an operation, just raised $20 million in equity. The new dollars will help Invuity up commercialization efforts across its broad range of, well, highly specialized specialized flashlights. Devices like its Eikon illuminated retractor, for instance, let surgeons delve into deep, dark cavities through […]
Medical software developer Heartflow just raised another hefty swath of cash. Isn’t it time the Bay area startup IPO’d? Heartflow’s diagnostic software reconfigures medical imaging data, particularly from CT scans, to build 3D models of patients’ coronary arteries for physicians to use. The company just raised $35.8 million of a potential $46.3 million round, according to a recent regulatory filing. Calls to […]
Two news items from Bay Area life sciences tools startup Unchained Labs: It just announced a $25 million Series A, and acquired a multiplex stability platform for biologics called Optim that will serve as the backbone of its business. With the funding, Unchained Labs plans to build on this Optim platform, and acquire more technologies to grow the biz […]
The Peter Thiel-backed Breakout Labs just funded three new life sciences startups: Neumitra, E3X Bio and Ion Dx – with platforms in the wearables, diagnostics and high-throughput screening spaces. They’re all prototypical Breakout Labs companies – super early stage, but showcasing an ambition and vision that shies away from playing it safe. “We’re after companies that have deep, […]
Nature’s been a fantastically bountiful source of medicine, sure. But turns out the drug compounds found secreted by a sea sponge or on the underside of a log have very elaborate chemical structures. When used for unintended purposes like, say, treating humans, these compounds can both help and harm. Third Rock Ventures just funneled an impressive $45 million to launch […]